ANC 0 3 0 3 B-clinical_variable
greater 4 11 4 11 O
than 12 16 12 16 O
500/µL 17 23 17 23 B-lower_bound

Active 0 6 24 30 O
and 7 10 31 34 O
uncontrolled 11 23 35 47 O
relapse 24 31 48 55 O
of 32 34 56 58 O
malignancy 35 45 59 69 B-cancer

Available 0 9 70 79 O
multivirus 10 20 80 90 B-treatment
- 20 21 90 91 I-treatment
specific 21 29 91 99 I-treatment
cytotoxic 30 39 100 109 I-treatment
T 40 41 110 111 I-treatment
lymphocytes 42 53 112 123 I-treatment

Bilirubin 0 9 124 133 B-clinical_variable
< 10 11 134 135 O
2x 11 13 135 137 B-upper_bound
, 13 14 137 138 O
AST 15 18 139 142 B-clinical_variable
< 19 20 143 144 O
3x 20 22 144 146 B-upper_bound
, 22 23 146 147 O
Serum 24 29 148 153 B-clinical_variable
creatinine 30 40 154 164 I-clinical_variable
< 41 42 165 166 O
2x 42 44 166 168 B-upper_bound
upper 45 50 169 174 I-upper_bound
limit 51 56 175 180 I-upper_bound
of 57 59 181 183 I-upper_bound
normal 60 66 184 190 I-upper_bound
, 66 67 190 191 O
Hgb 68 71 192 195 B-clinical_variable
> 72 73 196 197 O
8.0 73 76 197 200 B-lower_bound

Early 0 5 201 206 O
treatment 6 15 207 216 B-treatment
for 16 19 217 220 O
single 20 26 221 227 B-chronic_disease
or 27 29 228 230 I-chronic_disease
multiple 30 38 231 239 I-chronic_disease
infections 39 49 240 250 I-chronic_disease
. 49 50 250 251 O
Multiple 51 59 252 260 B-chronic_disease
infections 60 70 261 271 I-chronic_disease
with 71 75 272 276 O
one 76 79 277 280 O
reactivation 80 92 281 293 O
and 93 96 294 297 O
one 97 100 298 301 O
controlled 101 111 302 312 O
infection 112 121 313 322 O
are 122 125 323 326 O
eligible 126 134 327 335 O
to 135 137 336 338 O
enroll 138 144 339 345 O

Evidence 0 8 346 354 O
of 9 11 355 357 O
GVHD 12 16 358 362 B-clinical_variable
> 17 18 363 364 O
grade 19 24 365 370 B-lower_bound
2 25 26 371 372 I-lower_bound

Karnofsky 0 9 373 382 B-clinical_variable
/ 9 10 382 383 I-clinical_variable
Lansky 10 16 383 389 I-clinical_variable
score 17 22 390 395 I-clinical_variable
of 23 25 396 398 O
≥ 26 27 399 400 O
50 28 30 401 403 B-lower_bound

Negative 0 8 404 412 B-pregnancy
pregnancy 9 18 413 422 I-pregnancy
test 19 23 423 427 O
( 24 25 428 429 O
if 25 27 429 431 O
female 28 34 432 438 B-gender
of 35 37 439 441 O
childbearing 38 50 442 454 O
potential 51 60 455 464 O
) 60 61 464 465 O

Patients 0 8 466 474 O
who 9 12 475 478 O
received 13 21 479 487 O
ATG 22 25 488 491 B-treatment
, 25 26 491 492 O
Campath 27 34 493 500 B-treatment
, 34 35 500 501 O
or 36 38 502 504 O
other 39 44 505 510 O
T 45 46 511 512 B-treatment
cell 47 51 513 517 I-treatment
immunosuppressive 52 69 518 535 I-treatment
monoclonal 70 80 536 546 I-treatment
antibodies 81 91 547 557 I-treatment
in 92 94 558 560 O
the 95 98 561 564 O
last 99 103 565 569 B-upper_bound
28 104 106 570 572 I-upper_bound
days 107 111 573 577 I-upper_bound

Patients 0 8 578 586 O
with 9 13 587 591 O
Grade 14 19 592 597 B-chronic_disease
3 20 21 598 599 I-chronic_disease
hyperbilirubinemia 22 40 600 618 I-chronic_disease

Patients 0 8 619 627 O
with 9 13 628 632 O
other 14 19 633 638 O
uncontrolled 20 32 639 651 B-chronic_disease
infections 33 43 652 662 I-chronic_disease
( 44 45 663 664 O
see 45 48 664 667 O
2.3.2 49 54 668 673 O
for 55 58 674 677 O
definitions 59 70 678 689 O
) 70 71 689 690 O

Pregnant 0 8 691 699 B-pregnancy

Prophylaxis 0 11 700 711 O
for 12 15 712 715 O
patients 16 24 716 724 O
at 25 27 725 727 O
risk 28 32 728 732 O
of 33 35 733 735 O
EBV 36 39 736 739 B-chronic_disease
, 39 40 739 740 O
CMV 41 44 741 744 B-chronic_disease
, 44 45 744 745 O
or 46 48 746 748 O
Adenovirus 49 59 749 759 B-chronic_disease

Pulse 0 5 760 765 B-clinical_variable
oximetry 6 14 766 774 I-clinical_variable
of 15 17 775 777 O
> 18 19 778 779 O
90 20 22 780 782 B-lower_bound
% 22 23 782 783 I-lower_bound
on 24 26 784 786 O
room 27 31 787 791 O
air 32 35 792 795 O

Received 0 8 796 804 O
donor 9 14 805 810 B-treatment
lymphocyte 15 25 811 821 I-treatment
infusion 26 34 822 830 I-treatment
in 35 37 831 833 O
last 38 42 834 838 B-upper_bound
28 43 45 839 841 I-upper_bound
days 46 50 842 846 I-upper_bound

Received 0 8 847 855 O
prior 9 14 856 861 O
myeoloablative 15 29 862 876 O
or 30 32 877 879 O
non 33 36 880 883 O
- 36 37 883 884 O
myeloablative 37 50 884 897 O
allogeneic 51 61 898 908 B-treatment
hematopoietic 62 75 909 922 I-treatment
stem 76 80 923 927 I-treatment
cell 81 85 928 932 I-treatment
transplant 86 96 933 943 I-treatment
using 97 102 944 949 O
either 103 109 950 956 O
bone 110 114 957 961 O
marrow 115 121 962 968 O
or 122 124 969 971 O
PBSC 125 129 972 976 B-clinical_variable
within 130 136 977 983 O
12 137 139 984 986 B-upper_bound
months 140 146 987 993 I-upper_bound

Steroids 0 8 994 1002 B-treatment
less 9 13 1003 1007 O
than 14 18 1008 1012 O
0.5 19 22 1013 1016 B-upper_bound
mg 23 25 1017 1019 I-upper_bound
/ 25 26 1019 1020 I-upper_bound
kg 26 28 1020 1022 I-upper_bound
/ 28 29 1022 1023 I-upper_bound
day 29 32 1023 1026 I-upper_bound
prednisone 33 43 1027 1037 B-treatment

Treatment 0 9 1038 1047 B-treatment
of 10 12 1048 1050 I-treatment
reactivation 13 25 1051 1063 I-treatment
or 26 28 1064 1066 I-treatment
infection 29 38 1067 1076 I-treatment
for 39 42 1077 1080 O
EBV 43 46 1081 1084 B-chronic_disease
, 46 47 1084 1085 O
CMV 48 51 1086 1089 B-chronic_disease
, 51 52 1089 1090 O
or 53 55 1091 1093 O
Adenovirus 56 66 1094 1104 B-chronic_disease

Unable 0 6 1105 1111 O
to 7 9 1112 1114 O
wean 10 14 1115 1119 O
steroids 15 23 1120 1128 B-treatment
to 24 26 1129 1131 O
≤0.5 27 31 1132 1136 O
mg 32 34 1137 1139 I-upper_bound
/ 34 35 1139 1140 I-upper_bound
kg 35 37 1140 1142 I-upper_bound
/ 37 38 1142 1143 I-upper_bound
day 38 41 1143 1146 I-upper_bound
prednisone 42 52 1147 1157 B-treatment

